{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:51Z","timestamp":1786998471872,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ygyno.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:42:39Z","timestamp":1737783759000},"page":"136-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated with definitive chemoradiotherapy"],"prefix":"10.1016","volume":"193","author":[{"given":"Yeon Joo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2025.01.009_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.009_bb0010","first-page":"15","article-title":"2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging","volume":"292","author":"Lee","year":"2019"},{"key":"10.1016\/j.ygyno.2025.01.009_bb0015","first-page":"2338","article-title":"The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings","volume":"13","author":"Ozsarlak","year":"2003"},{"issue":"30","key":"10.1016\/j.ygyno.2025.01.009_bb0020","first-page":"7454","article-title":"Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the united states: results of intergroup protocol ACRIN 6651\/GOG 183","volume":"23","author":"Amendola","year":"2005"},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.009_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2214\/ajr.168.2.9016214","article-title":"Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging","volume":"168","author":"Kim","year":"1997","journal-title":"Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.009_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.10.012","article-title":"Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?","volume":"101","author":"Rockall","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"994","key":"10.1016\/j.ygyno.2025.01.009_bb0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1259\/bjr\/6646798","article-title":"Prognostic significance of MRI-detected bladder muscle and\/or serosal invasion in patients with cervical cancer treated with radiotherapy","volume":"83","author":"Nam","year":"2010","journal-title":"Br. J. Radiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2025.01.009_bb0040","article-title":"Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Quinn","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2025.01.009_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12885-016-2268-3","article-title":"The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy","volume":"16","author":"Wakatsuki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2025.01.009_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2023.11.011","article-title":"Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement","volume":"180","author":"Sammouri","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.009_bb0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/IGC.0b013e3181d224c8","article-title":"Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer?","volume":"20","author":"Biewenga","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2025.01.009_bb0060","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.18632\/oncotarget.24271","article-title":"Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae","volume":"9","author":"Sun","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ygyno.2025.01.009_bb0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/030089161209800512","article-title":"Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer","volume":"98","author":"Lee","year":"2012","journal-title":"Tumori Journal"},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.009_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1040-8428(03)00123-9","article-title":"Guidelines of how to manage vesicovaginal fistula","volume":"48","author":"Angioli","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.01.009_bb0075","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00192-019-04217-z","article-title":"Surgical outcomes of vesicovaginal fistulae in patients with previous pelvic radiotherapy","volume":"31","author":"Toia","year":"2020","journal-title":"Int. Urogynecol. J."},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.009_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eururo.2008.04.044","article-title":"Management of radiation-induced vesicovaginal fistula","volume":"55","author":"Pushkar","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ygyno.2025.01.009_bb0085","series-title":"Vesicovaginal\/Rectovaginal Fistula Formation and Outcome of Stage IVA Carcinoma of the Cervix Treated with Radiotherapy","author":"Kinjyo","year":"2017"},{"issue":"68","key":"10.1016\/j.ygyno.2025.01.009_bb0090","doi-asserted-by":"crossref","first-page":"112855","DOI":"10.18632\/oncotarget.22836","article-title":"Radiation therapy for stage IVA uterine cervical cancer: treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas","volume":"8","author":"Hata","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.009_bb0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2022.05.022","article-title":"Overall survival in patients with FIGO stage IVA cervical cancer","volume":"166","author":"Schiff","year":"2022","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:57:21Z","timestamp":1773835041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":19,"alternative-id":["S0090825825000216"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated with definitive chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}